CJ Bioscience, Inc.: Clinical Trials

1 trial sponsored by CJ Bioscience, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow CJ Bioscience, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
CJRB-101, Pembrolizumab injection - NSCLC, HNSCC
Phase 1 / Phase 2RecruitingCJ Bioscience, Inc.1602023-09-112024-12-20

Conditions studied

Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Interventions

pembrolizumab (1)

Countries

South Korea (1)  ·  United States (1)

Results publications

PMID 42140743